# Phase 1 Final Closeout V0

**Status:** Final closeout artifact

**Closeout date:** 2026-09-03

This artifact closes the repository-owned Phase 1 engineering and baseline
research cycle. It does not promote any strategy and does not inspect the
validation holdout.

## Final State

| Area | Status |
| --- | --- |
| Phase 1 engineering vertical slice | Complete |
| B001 research run | Rejected |
| B002 research run | Rejected |
| B003 research run | Rejected |
| Validation holdout | Uninspected |
| B001-S015, B002-S015, B003-S015 | Unrun robustness rows |
| Strategy promoted from Phase 1 | No |
| Repo-owned Phase 1 closeout | Complete |
| Real broker reconciliation | Conditional external follow-up if a suitable record is available |

## Research Outcome

B001, B002, and B003 were run only on the pre-registered research period:

```text
2016-01-01 through 2022-12-31
```

All three were rejected before any validation-period inspection:

| Experiment | Turnover Gate | Drawdown Gate | Final Status |
| --- | --- | --- | --- |
| B001 | FAIL | FAIL | REJECTED |
| B002 | FAIL | FAIL | REJECTED |
| B003 | PASS | FAIL | REJECTED |

No Phase 1 strategy candidate is eligible for validation promotion.

## Holdout Status

The validation holdout remains sealed:

```text
2023-01-01 through 2026-08-19
```

Do not run B001, B002, B003, B001-S015, B002-S015, or B003-S015 on this
period as a promotion test. The S015 rows are higher-slippage robustness rows,
not rescue trials.

## Evidence Register

| Evidence | Artifact |
| --- | --- |
| Research-stage outcome review | `docs/validation/PHASE1_RESEARCH_REVIEW_V0.md` |
| Research postmortem | `docs/validation/PHASE1_RESEARCH_POSTMORTEM_V0.md` |
| Closeout status before final signoff | `docs/validation/PHASE1_CLOSEOUT_STATUS_V0.md` |
| Frozen universe | `universes/nifty100_v0_20.csv` |
| Universe selection rule | `universes/selection_rule_v0.md` |
| Processed dataset manifest | `docs/validation/PROCESSED_DATASET_V0.md` |
| Market-data validation | `docs/validation/MARKET_DATA_VALIDATION_V0.md` |
| Legacy source bridge validation | `docs/validation/LEGACY_UDIFF_SEAM_VALIDATION_V0.md` |
| Corporate-action full-window scan | `docs/validation/CORPORATE_ACTION_FULL_WINDOW_SCAN_V0.md` |
| Corporate-action visual validation | `docs/validation/CORPORATE_ACTION_VISUAL_VALIDATION_V0.md` |
| Benchmark validation | `docs/validation/NIFTY100_TRI_BENCHMARK_V0.md` |
| Synthetic reconciliation | `docs/validation/THREE_TRADE_HAND_RECONCILIATION_V0.md` |
| Experiment ledger | `experiments/ledger.csv` |
| B001 research report | `experiments/results/B001_research/phase1_report.md` |
| B002 research report | `experiments/results/B002_research/phase1_report.md` |
| B003 research report | `experiments/results/B003_research/phase1_report.md` |

## Remaining External Evidence

Real Zerodha delivery cost reconciliation remains a conditional external
follow-up because no suitable broker contract note, funds statement, or
equivalent record is committed to the repository. If such a record becomes
available, reconcile it against the dated cost profile before relying on the
profile for paper or live trading.

This conditional item does not change the Phase 1 research outcome: no strategy
was promoted, and the validation holdout remains unspent.

## Next Research Rule

Any new strategy, risk overlay, universe change, rebalance rule, cost
assumption, or parameter choice must receive a new experiment ID and be
pre-registered before execution. The validation holdout remains sealed until a
genuinely new candidate passes its own research-period gates.

Use `docs/validation/PHASE2_HYPOTHESIS_INTAKE_TEMPLATE.md` as the intake
checklist before creating any new post-Phase 1 pre-registration artifact.
